Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...

7,8 VOQUEZNA® (vonoprazan) tablets contain vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach.

Voquezna (vonoprazan) is a brand-name oral tablet prescribed for certain stomach and esophagus conditions in adults. Voquezna also comes in combination packages. It’s typically taken once or ...

Please visit voqueznapro.com to learn more about VOQUEZNA. VOQUEZNA® (vonoprazan) tablets contain vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel ...

Other medications can affect the removal of vonoprazan from your body, which may affect how vonoprazan works. Examples include rifamycins (such as rifabutin), among others. Do not share this ...

(vonoprazan) products, launch to date, a 138% increase since last quarterly report Commercial access for VOQUEZNA tablets expanded, now covering over 80% of U.S. commercial lives Management to host ...

In November 2023, Phathom Pharmaceuticals announced that VOQUEZNA® (vonoprazan) Tablets received FDA approval for treating adults with erosive GERD and relieving heartburn related to the condition.